首页 | 本学科首页   官方微博 | 高级检索  
     

多西他赛同步放疗治疗老年晚期非小细胞肺癌
引用本文:刘海燕,张艳英,宋延梅. 多西他赛同步放疗治疗老年晚期非小细胞肺癌[J]. 实用医药杂志(山东), 2006, 23(7): 786-788
作者姓名:刘海燕  张艳英  宋延梅
作者单位:泰山医学院附属医院肿瘤科,山东泰安271000
摘    要:
目的观察多西他赛同步放疗治疗老年晚期非小细胞肺癌(NSCLC)的疗效及毒副反应。方法对病理学或细胞学证实的32例老年晚期非小细胞肺癌患者给予下列治疗:①多西他赛35mg/m2,静脉滴注,于放疗前1d开始,1次/周,共4次;②给予6-mVX-线常规体外照射,1.8~2Gy/次,5次/周,总量50~60Gy/5~6周。结果初治患者有效率86.4%,复治患者有效率40%,总有效率68.8%,中位生存期10个月。不良反应:食管炎56.4%,白细胞减少46.4%,放射性肺炎17.6%。无治疗相关的病死。结论多西他赛同步放疗治疗老年晚期NSCLC疗效满意,耐受性好。

关 键 词:多西他赛  放射治疗  老年  非小细胞肺癌
修稿时间:2006-04-21

Concurrent taxotere and radiotherapy for elderly patients with advanced non-small cell lung cancer
LIU Hai-yan,ZHANG Yan-ying,SONG Yan-mei. Concurrent taxotere and radiotherapy for elderly patients with advanced non-small cell lung cancer[J]. Practical Journal of Medicine & Pharmacy, 2006, 23(7): 786-788
Authors:LIU Hai-yan  ZHANG Yan-ying  SONG Yan-mei
Affiliation:LIU Hai-yan ZHANG Yan-ying SONG Yan-mei. Department of Oncology-Affiliated Hospital of Taishan Medical College Tai'an 271000 China
Abstract:
Objective To evaluate the therapeutic significance of concurrent taxotere and radiotherapy for elderly patients with advanced non-small cell lung cancer(NSCLC).Methods Elderly patients with advanced NSCLC received 6-MV X rays at split-course schedule with the total dose of 50-60Gy/5-6 weeks and taxotere-35mg/m2-administered on the first day of each radiotherapy week.Results Of 32 patients enrolled-the objective response occurred in 86.4% of chemo-navepatients and 40% of the others-the overall response rate was 68.8%.The media duration of survival was 8.5 months.The more frequent toxicities were esophagitis-leucopenia and pneumonitis (56.4%-46.4% and 17.6%-respectively).No serious toxicity and treatment related death occurred.Conclusion This regiment was well-tolerated and effective in elderly patients with advanced NSCLC.
Keywords:Taxotere Radiotherapy Elder Non-small-cell lung cancer  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号